Summit Wealth & Retirement Planning’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Summit Wealth & Retirement Planning's BMY Position: Q3 2022 in Review
Summit Wealth & Retirement Planning sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 3,755 shares — an estimated $289K sold.
Summit Wealth & Retirement Planning first reported a position in BMY in Q4 2018 and held it in 15 quarters. The position peaked at $823K in Q4 2019. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.
- Summit Wealth & Retirement Planning reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
- Summit Wealth & Retirement Planning sold 3,755 Bristol-Myers Squibb shares in Q3 2022, an estimated $289K.
- Summit Wealth & Retirement Planning first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 15 quarters.
- Summit Wealth & Retirement Planning's Bristol-Myers Squibb position peaked at $823K in Q4 2019.
- 2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.
Based on Summit Wealth & Retirement Planning's 13F filing for Q3 2022, filed 14 Nov 2022.